Thora J Jonasdottir Selected Research

Surgical Amputation (Amputations)

7/2013

HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thora J Jonasdottir Research Topics

Disease

5	Neoplasms (Cancer) 01/2016 - 07/2006
2	Lymphoma (Lymphomas) 01/2010 - 09/2007
1	Circulating Neoplastic Cells 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Osteosarcoma (Osteogenic Sarcoma) 01/2016

Drug/Important Bio-Agent (IBA)

5	Radioisotopes (Radionuclides)IBA 01/2016 - 07/2006
2	Immunoconjugates (Immunoconjugate)IBA 01/2016 - 09/2007
1	Immunoglobulin G (IgG)IBA 01/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	AntibodiesIBA 01/2016
1	AntigensIBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2013
1	Messenger RNA (mRNA)IBA 07/2013
1	Rituximab (Mabthera)FDA Link 01/2010
1	Thorium-227IBA 09/2007
1	Liposomes (Liposome)IBA 07/2006

Therapy/Procedure

1	Radioimmunotherapy 01/2016
1	Drug Therapy (Chemotherapy) 07/2013
1	Surgical Amputation (Amputations) 07/2013
1	Therapeutics 09/2007